A top Indian virologist has resigned from a forum of scientific advisers set up by the government to detect variants of the coronavirus, he told Reuters on Sunday, weeks after questioning the authorities’ handling of the pandemic.
Shahid Jameel, chair of the scientific advisory group of the forum known as INSACOG, declined to give a reason for his resignation.
“I am not obliged to give a reason,” he said in a text message, adding that he quit on Friday.
Renu Swarup, the secretary of the Department of Biotechnology that oversees INSACOG, did not immediately respond to a request for comment. Health Minister Harsh Vardhan also did not immediately respond to a text message seeking comment.
Another INSACOG member said he was not aware of any direct disagreements between Jameel and the government.
A top government scientist who is part of the forum said, on the condition of anonymity, that he did not think the departure of Jameel would hamper INSACOG’s monitoring of virus variants.
Reuters reported earlier this month that INSACOG, the Indian SARS-CoV-2 Genetics Consortium, warned government officials in early March of a new and more contagious variant of the coronavirus taking hold in the country. The variant, B.1.617, is one of the reasons India is currently battling the world’s worst surge in COVID-19 cases.
Asked why the government did not respond more forcefully to the findings, for example by restricting large gatherings, Jameel had told Reuters that he was concerned that authorities were not paying enough attention to the evidence as they set policy.
UK confident vaccines protect against Indian variantBritain is confident that existing vaccines will provide protection from a more transmissible Indian coronavirus variant now spreading across the ... Coronavirus
India police jail 21 Kashmiris amid pro-Palestinian ralliesPolice in Indian-controlled Kashmir said Saturday that 21 people were arrested for disturbing public order by expressing solidarity with Palestinians ... Middle East
Supply of COVID-19 drug remdesivir catching up with demand in India: CiplaIndia’s Cipla said on Saturday that its manufacturing of the COVID-19 remdesivir drug was beginning to catch up with demand after the company sought ... Coronavirus
India’s daily COVID-19 deaths near 4,000, WHO flags concernIndia reported a smaller rise in daily coronavirus infections on Saturday, but deaths stayed near the 4,000 mark, with the World Health Organization ... Coronavirus
India’ Modi says ‘feeling’ his nation’s COVID-19 painIndia’s Prime Minister Narendra Modi has said he feels the pain of all Indians battling the pandemic, in a televised address Friday following weeks of ... Coronavirus